Expression of IL-17 mRNA in Ovarian Cancer
- 1 April 2001
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 282 (3), 735-738
- https://doi.org/10.1006/bbrc.2001.4618
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Angiogenesis of the ovaryAmerican Journal of Obstetrics and Gynecology, 2000
- Interleukin-17-induced Gene Expression in Articular Chondrocytes Is Associated with Activation of Mitogen-activated Protein Kinases and NF-κBJournal of Biological Chemistry, 1998
- IL-17 Stimulates the Production and Expression of Proinflammatory Cytokines, IL-β and TNF-α, by Human MacrophagesPublished by The American Association of Immunologists ,1998
- Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levelsBritish Journal of Cancer, 1997
- The Expression of Vascular Endothelial Growth Factor and Transforming Growth Factor-β Associates With Angiogenesis in Epithelial Ovarian CancerInternational Journal of Gynecological Pathology, 1997
- Interleukin‐17 up‐regulation of nitric oxide production in human osteoarthritis cartilageArthritis & Rheumatism, 1997
- T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.The Journal of Experimental Medicine, 1996
- Human IL-17: a novel cytokine derived from T cells.The Journal of Immunology, 1995
- CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene.The Journal of Immunology, 1993
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991